DPP4 and diabetic retinopathy: We tested the hypothesis of whether DPP4-inhibitors, by stimulating the SDF-1α/CXCR4 axis and subsequently resulting in Src-mediated phosphorylation of VE-cadherin, would increase vascular permeability, which is a key process in diabetic retinopathy.